These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10435199)

  • 21. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
    Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
    Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.
    Betancur C; Lépée-Lorgeoux I; Cazillis M; Accili D; Fuchs S; Rostène W
    Neuropsychopharmacology; 2001 Feb; 24(2):170-82. PubMed ID: 11120399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.
    Ma J; Ye N; Cohen BM
    Neuroscience; 2006 Sep; 141(3):1469-80. PubMed ID: 16781818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal dopamine receptor plasticity in neurotensin deficient mice.
    Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
    Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of haloperidol, quinelorane, and lithium on regional neurotensin/neuromedin N concentrations: further evidence for neurotensin/neuromedin N-dopamine interactions.
    Clement R; Griff D; Banks B; Nemeroff C; Kitabgi P; Bissette G
    Synapse; 1994 Aug; 17(4):241-6. PubMed ID: 7992199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin-deficient mice show altered responses to antipsychotic drugs.
    Dobner PR; Fadel J; Deitemeyer N; Carraway RE; Deutch AY
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):8048-53. PubMed ID: 11427716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
    Stowe ZN; Bissette G; Nemeroff CB
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):49-59. PubMed ID: 1679273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do neuropeptide systems mediate some of the effects of antipsychotic drugs?
    Bissette G; Nemeroff CB
    Prog Clin Biol Res; 1985; 192():349-53. PubMed ID: 2867552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
    Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
    J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
    Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
    J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions.
    Merchant KM; Dobie DJ; Filloux FM; Totzke M; Aravagiri M; Dorsa DM
    J Pharmacol Exp Ther; 1994 Oct; 271(1):460-71. PubMed ID: 7965747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone does not elevate neurotensin mRNA in rat nucleus accumbens and caudate-putamen.
    Mijnster MJ; Docter GJ; Voorn P
    Neuroreport; 1995 Nov; 6(16):2209-12. PubMed ID: 8595204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin receptor agonists and antagonists for schizophrenia.
    Robertson VB; Wilson MS
    Am J Psychiatry; 2005 Mar; 162(3):634; author reply 635. PubMed ID: 15741502
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of acute antipsychotic drug administration on the neurotensin system of the developing rat brain.
    Kinkead B; Owens MJ; Nemeroff CB
    Brain Res Dev Brain Res; 2000 Nov; 124(1-2):1-10. PubMed ID: 11113506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
    Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
    J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
    Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB
    Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered neurotensin mrna expression in mice lacking the dopamine transporter.
    Roubert C; Spielewoy C; Soubrié P; Hamon M; Giros B; Betancur C
    Neuroscience; 2004; 123(2):537-46. PubMed ID: 14698760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
    Kapur S; Zipursky R; Jones C; Remington G; Houle S
    Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.